US EditionPublished • loading... • Updated
GlaxoSmithKline Takes Over Entirety of Cambridge Building
Summary by Connect CRE
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
GlaxoSmithKline Takes Over Entirety of Cambridge Building
British pharmaceutical giant GlaxoSmithKline is growing its Cambridge, MA footprint and workforce, taking over the entirety of King Street Properties’ 222,000-square-foot 200 CambridgePark Dr. in Cambridge, a six-story building that will eventually house about 400 workers. The Boston Business Journal reported that the expansion comes after GSK announced earlier this year that it will move its vaccine R&D and infectious disease teams to Cambridge…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
